Posts Tagged ‘ME/CFS Biomarker’
Progress in ME/CFS Subset Identification
When it comes to biomarker discovery and clinical trials, disease heterogeneity is the bane of clinical researchers existence. I am showing my age here, but think of it like static on the radio: too much noisy static makes it hard to hear the nice music sound and when you tune in, the signal is loud…
Read MoreNASA 10-Minute Lean Test
A Simple Way to Assess Orthostatic Intolerance On June 7, 2017, at the monthly BHC Education Meeting, Pelle Wall, BHC Research Coordinator, reviewed the procedure and shared information about the research underway. Orthostatic intolerance (OI) is an umbrella term used to describe abnormal autonomic nervous system response to orthostatic challenge. Orthostatic hypotension (OH), neurally mediated hypotension (NMH) [or…
Read MoreDifferences So Clear
New Research Brings Clear Differences to Light in ME/CFS by Suzanne D. Vernon, PhD | BHC Research Liaison There is a great song in the musical RENT titled “Seasons of Love” in which they sing about the number of minutes in a year. As I am reviewing and writing this summary of the recent paper, “Epigenetic…
Read MoreGlobal Report of Progress with Lucinda Bateman, M.D.
An ME/CS Progress Report Lucinda Bateman, MD, BHC Founder and Medical Director, is actively engaged in ME/CFS and FM thought leadership across the globe. In October she was on the road to take part in and advance the discussions that lead to progress. In a few short weeks she participated in: October 8th – SMCI Scientific…
Read MoreWhat’s the Buzz – October
Buzz – October: Each month we scour the Internet to bring you a summary of news articles, blogs and research publications we think you’ll find interesting for our What’s the Buzz post. This month, Suzanne D. Vernon, PhD, BHC Research Liaison, highlights and summarize two recent research publications for you: The Importance of Measuring Symptoms ME/CFS is…
Read MoreSimple Way to Assess Orthostatic Intolerance
NASA 10 Minute Lean Test* Orthostatic intolerance (OI) is an umbrella term used to describe abnormal autonomic nervous system response to orthostatic challenge. Orthostatic hypotension (OH), neurally mediated hypotension (NMH) [or neurogenic hypotension] and postural orthostatic tachycardia syndrome (PoTS) are terms used to describe variants of this response. The new evidence-based IOM clinical criteria for…
Read MoreWhat’s the Buzz – July
Buzz – July: Each month we scour the Internet and bring you a list of news articles, blogs and research publications we think you’ll find interesting for our What’s the Buzz post. Occasionally, we’ll highlight and summarize a few of them for you, like this one: Could Difference in Gut Bacteria Help Explain ME/CFS Symptoms? Suzanne D.…
Read MoreBiomarkers or Bust
Dr. Vernon explains why for the Bateman Horne Center, the identification of biomarkers is mission-critical… It’s Biomarkers or Bust! __________ Back in 2008 when I was advocating on the Hill and at NIH for greater research dollars for ME/CFS research I was told, “Identify biomarkers and increased research dollars will follow.” A Catch 22 if…
Read More$3.28 Million Awarded for ME/CFS Biomarker Study
Bateman Horne Center Leadership are Co-Investigators on this Cutting-Edge Immunogenomic Study to Quantify ME/CFS Moving Toward a Genomic CBC for ME/CFS By Suzanne D Vernon, PhD There are two major barriers to identifying ME/CFS biomarkers: 1) variation in how patients are effected, in terms of symptoms and disease progression and 2) the lack of quantitative tools…
Read MorePrecision Medicine for ME/CFS & Fibromyalgia
In this educational seminar, Dr. Suzanne D. Vernon speaks about the Bateman Horne Center’s quest to bring precision medicine to ME/CFS and Fibromyalgia. What is precision medicine and why do we need it? Precision medicine is an approach that takes into account individual variability in genes, environment, and lifestyle for each person. The goal of precision…
Read More